Confluence Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-84,017
Closed -$1.61M 314
2022
Q2
$1.61M Sell
84,017
-17,152
-17% -$325K 0.03% 185
2022
Q1
$2.02M Sell
101,169
-14,311
-12% -$289K 0.03% 180
2021
Q4
$2.36M Sell
115,480
-28,989
-20% -$619K 0.03% 177
2021
Q3
$3.11M Sell
144,469
-67,792
-32% -$1.63M 0.04% 172
2021
Q2
$6.13M Buy
212,261
+4,065
+2% +$110K 0.08% 139
2021
Q1
$5.08M Buy
208,196
+25,869
+14% +$584K 0.07% 147
2020
Q4
$3.54M Buy
182,327
+10,649
+6% +$196K 0.05% 167
2020
Q3
$2.99M Buy
171,678
+3,442
+2% +$73.4K 0.05% 164
2020
Q2
$4.42M Buy
168,236
+1,756
+1% +$43.6K 0.07% 136
2020
Q1
$4.02M Buy
166,480
+23,905
+17% +$584K 0.08% 137
2019
Q4
$4.53M Sell
142,575
-1,794
-1% -$41.6K 0.07% 157
2019
Q3
$3.08M Buy
144,369
+1,794
+1% +$49.1K 0.05% 169
2019
Q2
$4.53M Buy
142,575
+4,234
+3% +$133K 0.07% 157
2019
Q1
$4.57M Buy
138,341
+24,361
+21% +$758K 0.08% 155
2018
Q4
$3.67M Buy
113,980
+47,051
+70% +$1.78M 0.07% 159
2018
Q3
$2.87M Buy
+66,929
New +$3.16M 0.05% 170

Other funds holding PAHC

Confluence Investment Management's PAHC Position: Q3 2022 in Review

Confluence Investment Management sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 84,017 shares — an estimated $1.61M sold.

Confluence Investment Management first reported a position in PAHC in Q3 2018 and held it in 16 quarters. The position peaked at $6.13M in Q2 2021. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • Confluence Investment Management reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • Confluence Investment Management sold 84,017 Phibro Animal Health shares in Q3 2022, an estimated $1.61M.
  • Confluence Investment Management first reported a position in Phibro Animal Health in Q3 2018 and held it in 16 quarters.
  • Confluence Investment Management's Phibro Animal Health position peaked at $6.13M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on Confluence Investment Management's 13F filing for Q3 2022, filed 3 Oct 2022.